QNRX vs ROL · $9.6M cap vs P/E 41, rev $1.99B
Quoin Pharmaceuticals Ltd DRC (QNRX) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Quoin Pharmaceuticals Ltd DRC (QNRX) is a biotechnology company listed on NASDAQ.
Rollins Inc (ROL) is a personal services company listed on NYSE.
QNRX does not have a complete income-statement cache yet.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
QNRX currently screens at market cap $9.6M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the QNRX and ROL stock pages for the full models.
Not investment advice.